A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
GlaxoSmithKline
GlaxoSmithKline
Immunitas Therapeutics
AVM Biotechnology Inc
Shattuck Labs, Inc.
MultiVir, Inc.
Amgen
Incyte Corporation
Valerio Therapeutics
INSYS Therapeutics Inc